糖尿病前期与糖尿病之间,仅一步之遥!

2016-09-28 常州市武进人民医院 周斌 医学界内分泌频道

糖尿病前期,并不是医生为了处方更多药物而创造出来的一个新疾病。相反,这个概念是为了提醒我们早期预防糖尿病,避免出现并发症和治疗复杂化。糖尿病的预防目标是在合适的干预时机,采取干预措施以减缓糖尿病前期人群发展为糖尿病的速度,或者终止糖尿病的发展,使高危人群向低危人群移动。所以,弄清楚糖尿病前期及其管理,对于对抗糖尿病有极其重要的意义。糖尿病的诊断想要了解糖尿病前期,首先要明确糖尿病的诊断标准。糖尿病

糖尿病前期,并不是医生为了处方更多药物而创造出来的一个新疾病。相反,这个概念是为了提醒我们早期预防糖尿病,避免出现并发症和治疗复杂化。


糖尿病的预防目标是在合适的干预时机,采取干预措施以减缓糖尿病前期人群发展为糖尿病的速度,或者终止糖尿病的发展,使高危人群向低危人群移动。所以,弄清楚糖尿病前期及其管理,对于对抗糖尿病有极其重要的意义。


糖尿病的诊断


想要了解糖尿病前期,首先要明确糖尿病的诊断标准。糖尿病的临床诊断应依据静脉血浆血糖,而非末梢血糖,《中国2型糖尿病防治指南(2013年版)》(以下简称“指南”)仍采用WHO(1999年)诊断标准。建议已达到糖调节受损,也称为糖尿病前期的人群,应行OGTT检查,以以降低糖尿病的漏诊率。


图1:糖代谢状态分类


图2:糖尿病诊断标准


糖尿病前期人群的管理


发现糖尿病前期的人群之后,便要针对不同情况进行个体化的管理,主要包括健康教育、生活方式和药物干预——


1、健康教育:参考糖尿病健康教育。


2、干预:


(1)强化生活方式干预:


必须再次强调,强化生活方式干预是基础。指南建议,糖尿病前期患者应通过饮食控制和运动以降低糖尿病的发生风险,并定期随访,给予社会心理支持,以确保患者的良好的生活方式能够长期坚持;另外,需定期检查血糖,同时密切关注其他心血管疾病危险因素(如吸烟、高血压、血脂紊乱等),并给予适当的干预措施。


(2)药物干预:


如严格执行生活方式干预6个月以上而血糖仍控制不佳,或高血糖进展,且年轻、经济条件好、有高的健康需求及医疗条件者可考虑使用药物,且必须进行充分的沟通。药物可选择二甲双胍、阿卡波糖或噻唑烷二酮类(罗格列酮、吡格列酮),治疗应遵从个体化原则。



(不同糖尿病前期人群干预方案)


糖尿病前期人群控制目标


1、血糖控制目标:


糖尿病前期人群理想的控制目标是将血糖水平逆转至糖耐量正常(NGT)水平。 如无法逆转至 NGT 水平,至少应尽力维持在糖尿病前期,力争阻止或延缓其进展为糖尿病。


理想水平:空腹血糖≤6. 1mmol/ L,OGTT 2hPG≤7. 8mmol/L。 自然餐后 2hPG≤7. 8mmol/L。


2、体重控制目标:肥胖或超重的糖尿病前期人群体重应减少5% ~ 10%,并使体重指数长期维持在健康水平。


3、心脑血管疾病(CCVD) 因素控制目标:




呼吸内科会诊病例


下面,我们结合一个临床会诊病例来具体分析糖尿病前期的诊断和治疗。


男性患者,47岁,右下肺炎。3月前体检发现空腹静脉血糖6.3mmol/L,OGTT后2h血糖10.5mmol/L,予饮食控制后全天血糖一度“正常”。嗜烟。入院时测身高172cm,体重70.5kg,BMI=23.83kg/m2,腰围88cm;查空腹静脉血糖6.66mmol/L,HbA1c 6.5%,监测空腹及三餐后2小时末梢血糖6.2-12.1-9.7-11.3mmol/L。


1、糖尿病的诊断成立吗? (诊断糖尿病前期,还是糖尿病?)


该患者在入院前3个月已存在糖尿病前期(IFG+IGT),经饮食控制后血糖下降。现处急性感染应激状态,空腹血糖6.66mmol/L,HbA1c 6.5%,尚不能诊断糖尿病,故暂诊断为糖尿病前期。可于出院2周后复查。


2、需要药物干预吗? (强化生活方式干预,还是药物干预?)

强化生活方式干预是基础;然而在与该患者进行充分沟通后,发现因其不能长期坚持强化生活方式干预,且有高血糖进展,同时经济条件较好、健康需求较高,故给予降糖药干预治疗:阿卡波糖50mg tid。另外,教育患者饮食控制、运动、戒烟,定期随访、监测血糖。


总结


糖尿病前期是2型糖尿病最重要的危险因素,及时发现糖尿病前期人群并进行有效管理,是预防糖尿病发生的关键。强化生活方式干预是最重要且安全、有效的措施,因此是基础,是首选。但是,“管住嘴、迈开腿”,说来容易、做来难,这类人群的依从性一般较差,因此对于执行强化生活方式十分困难者、或强化生活方式干预6个月以上血糖仍不达标者,均可考虑药物干预。但须遵循个体化原则决定干预方式。


总之,尽可能把糖尿病关在门外!


参考文献:

1.中华医学会糖尿病学分会主编. 中国2型糖尿病防治指南(2013年版). 北京大学医学出版社,2014.10:5-11;

2.中华医学会内分泌学分会. 中国成人2型糖尿病预防的专家共识. 中华内分泌代谢杂志,2014,30(4):277-283;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=165800, encodeId=c20116580064, content=生活干预非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e4105146, createdName=wolixiang2012, createdTime=Mon Dec 26 13:46:56 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144721, encodeId=f758144e218c, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:58 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144719, encodeId=489d144e19ed, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:53 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140561, encodeId=9757140561e8, content=讲的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Wed Oct 05 20:35:39 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138583, encodeId=c5e21385837a, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:57:03 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138582, encodeId=f57a138582ca, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:56:43 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-12-26 wolixiang2012

    生活干预非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=165800, encodeId=c20116580064, content=生活干预非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e4105146, createdName=wolixiang2012, createdTime=Mon Dec 26 13:46:56 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144721, encodeId=f758144e218c, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:58 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144719, encodeId=489d144e19ed, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:53 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140561, encodeId=9757140561e8, content=讲的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Wed Oct 05 20:35:39 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138583, encodeId=c5e21385837a, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:57:03 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138582, encodeId=f57a138582ca, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:56:43 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-10-11 1e0d99ddm02(暂无匿称)

    总结的很好!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=165800, encodeId=c20116580064, content=生活干预非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e4105146, createdName=wolixiang2012, createdTime=Mon Dec 26 13:46:56 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144721, encodeId=f758144e218c, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:58 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144719, encodeId=489d144e19ed, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:53 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140561, encodeId=9757140561e8, content=讲的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Wed Oct 05 20:35:39 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138583, encodeId=c5e21385837a, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:57:03 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138582, encodeId=f57a138582ca, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:56:43 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-10-11 1e0d99ddm02(暂无匿称)

    分享一下!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=165800, encodeId=c20116580064, content=生活干预非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e4105146, createdName=wolixiang2012, createdTime=Mon Dec 26 13:46:56 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144721, encodeId=f758144e218c, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:58 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144719, encodeId=489d144e19ed, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:53 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140561, encodeId=9757140561e8, content=讲的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Wed Oct 05 20:35:39 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138583, encodeId=c5e21385837a, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:57:03 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138582, encodeId=f57a138582ca, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:56:43 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-10-05 1e0d99ddm02(暂无匿称)

    讲的很好!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=165800, encodeId=c20116580064, content=生活干预非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e4105146, createdName=wolixiang2012, createdTime=Mon Dec 26 13:46:56 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144721, encodeId=f758144e218c, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:58 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144719, encodeId=489d144e19ed, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:53 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140561, encodeId=9757140561e8, content=讲的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Wed Oct 05 20:35:39 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138583, encodeId=c5e21385837a, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:57:03 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138582, encodeId=f57a138582ca, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:56:43 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-10-01 doctorJiangchao

    继续关注

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=165800, encodeId=c20116580064, content=生活干预非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2e4105146, createdName=wolixiang2012, createdTime=Mon Dec 26 13:46:56 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144721, encodeId=f758144e218c, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:58 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144719, encodeId=489d144e19ed, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Tue Oct 11 17:01:53 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140561, encodeId=9757140561e8, content=讲的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Wed Oct 05 20:35:39 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138583, encodeId=c5e21385837a, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:57:03 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138582, encodeId=f57a138582ca, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 14:56:43 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-10-01 doctorJiangchao

    继续学习

    0

相关资讯

J Intern Med:高脂肪低碳水化合物饮食模式会对糖尿病患者的心理健康产生什么影响?

虽然可以通过极低碳水化合物、高脂肪饮食(LC)对2型糖尿病患者进行管理,但是饮食对心理健康的影响仍然是未知的。本研究旨在评估LC饮食对心理健康的长期影响。 研究纳入了115名肥胖的2型糖尿病成年患者,年龄58.5±7.1岁,BMI 34.6 ± 4.3 kg/m2,HbA1c 7.3 ± 1.1%。将这些患者随机分到热量限制组(~6 to 7 MJ)、计划性等热量的LC饮食组或高碳水化合物、

PLOS Genet:起来吧!新研究发现耐力训练可以改变基因活性

最近,来自瑞典卡罗林斯卡医学院的研究人员报告称耐力训练能够改变许多基因的活性。相关研究结果发表在国际学术期刊PLOS Genetics上。 常规的耐力训练对健康有益,可以预防心血管疾病,糖尿病,肥胖及其他健康问题。但是科学家们对于分子水平上发生了什么样的变化还不是特别清楚。 卡罗林斯卡医学院的研究人员分析了耐力训练前后肌肉组织中RNA的变化情况。他们发现与2600个基因有关的大约340

糖尿病并发症筛查,是“必修课”!

糖尿病的各种严重并发症令人生畏,它能够影响病人的生活质量和生存寿命,是造成糖尿病患者致残致死的罪魁祸首。从治疗的角度来讲,糖尿病的治疗目的绝不仅仅是降糖,更重要的是要尽量避免或及早治疗糖尿病并发症;而患者最担心的、最想知道的也莫过于自己是否有糖尿病并发症。因此,对糖尿病患者进行并发症的筛查是不可或缺的“必修课”。那么,需要给患者检查哪些项目呢?一、对动脉粥样硬化危险因素的筛查糖尿病慢性并发症是包括

Int J Epidemiol:摄入高水平的支链氨基酸也会增加糖尿病风险?

近期有研究显示,血浆支链氨基酸(BCAAs,包括亮氨酸、异亮氨酸和缬氨酸)与2型糖尿病的风险相关。膳食摄入是支链氨基酸的唯一来源;习惯性饮食摄入BCAAs对2型糖尿病又会有什么影响呢? 我们对来自三项前瞻性队列(护士健康研究(NHS;从1980到2012年);NHS II(从1991到2011年);卫生专业人员随访研究(HPFS;从1986到2010年))的参与者进行了研究,评估BCAAs的

Diabetologia:20年研究发现,它能延长糖尿病患者寿命多达8年

糖尿病患者,如何才能活得更久活得更好?近日,欧洲的科学家发现,专注于在早期对患者全方位强化管理,可使2型糖尿病中老年患者寿命延长8年之久,且在寿命延续期间也没有出现严重并发症。这将激发糖尿病研究领域转向于“老龄健康,延年益寿”策略。相关研究成果发布在欧洲糖尿病研究学会官方期刊《Diabetologia》上。糖尿病是由于人体内糖代谢紊乱而导致的一系列健康问题。它是一种慢性病,波及全球数亿人,而且发病